Artificial Pancreas Device Systems Market By Type (Threshold Suspend Device System, Control-to-Range (CTR) System, Control-to-Target (CTT) System) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global artificial pancreas device systems (APDS) studies the overall market scenario, the ongoing trends, future commercial prospects, and the competition in the artificial pancreas device systems market. For this study, the global artificial pancreas device systems market is studied for device type and geographical distribution. In addition, this study estimates the prospects of the APDS post introduction of certain target devices in the diabetes market. It is to be noted that the APDS thus described you do not involve biomaterial, synthetic tissue or organs and bionic substitutes.

Based on device types, the global artificial pancreas device systems market is categorized into threshold suspended device systems, control-to-range (CTR) systems, and control-to-target (CTT) systems segments. The market estimates in terms of revenue forecast for each of these segments from their product launch until the year 2022 are provided in this study, along with their respective CAGRs for the corresponding periods through 2022. The artificial pancreas device systems market has been geographically categorized into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K., Germany, China, and Japan. Market size and forecast for these segments from 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

Apart from the quantitative information, this report includes qualitative information sets such as drivers, challenges and opportunities, market inclination insights, major commercial events, device mechanism of artificial pancreas device systems, and benefits to the stakeholders in this market. This report also includes tools such as attractive investment proposition, Porter’s Five Forces model, and market positioning of key players to assess the overall market competition. This report concludes with profiles of certain market players that have a foothold in global diabetes management and, prospective pipelines in the artificial pancreas device systems market.

The major key players profiled in the artificial pancreas device systems market are based on business description, financial health, budget allocation, product portfolio, and news coverage. The major players profiled in this report include Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., and JDRF.

Type of Device Segmentation Investigation

Based on the type of devices, the global artificial pancreas device systems market is segmented as follows:

  • Threshold Suspend Device System
  • Control-to-Range (CTR) System
  • Control-to-Target (CTT) System

The concept of the artificial pancreas has eventually evolved into a mega project over these years that involve some of the biggest names in the diabetes management device market. The mission to develop a fully automated artificial pancreas system has already moved to its later stage, and the products are close to commercialization. According to World Health Organization (WHO), As of 2013, 382 Mn(or 8.3% of adults) people lived with diabetes, with 46% of the pool left undiagnosed. It is anticipated that by 2035, this patient population pool will reach 592 Mn with 55% undiagnosed individuals. The burden of diabetes is gigantic, with approximately USD 548 Bn spent on diabetes treatment and management in 2013 alone. Huge support and enthusiasm for research institutions and corporations have witnessed a transition in this field over the last decade.

In 2015, MiniMed 530G, Medtronic’s first generation artificial pancreas device, was commercialized in the market and resulted in a noticeable growth. The device was based on threshold suspend technology which is a proprietary technology of Medtronic, Inc. and is expected to achieve an early bird advantage in the market. Hence, during the forecast period, the threshold for suspending the device system is anticipated to be the largest segment. However, in 2018 five companies are expected to enter the market with advanced technologies based on the control-to-target (CTT) system. With their entry market is expected to boost with significant growth.

For this study, the global artificial pancreas device systems market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The geographical segmentation of the artificial pancreas device systems market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In the base year 2015, North America accounted for the largest market in the artificial pancreas device systems market due to large-scale research and academic studies being conducted in U.S. for further exploring the perfect design of artificial pancreas is expected to majorly drive the North America artificial pancreas device market. The major key players are based in North America, which is also considered an added advantage. The Asia Pacific and Latin America are expected to project the highest growth after 2022 as the cost of artificial pancreas devices and systems is predicted to be high, and most of the low-income countries from these regions will be difficult to penetrate with it. However, the artificial pancreas device systems market is expected to achieve maturity by 2022, which would intensify the market competition, revamp pricing strategies, and emphasize geographical expansion and penetration. Thus, the artificial pancreas device systems market in Asia Pacific and Latin America is expected to grow at an exceptional rate after 2022.

Frequently Asked Questions:

The market for Artificial Pancreas Device Systems is expected to reach US$ XX Bn in 2022.

The Artificial Pancreas Device Systems market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2016-2022.

The base year of this report is 2021.

Medtronic, Inc., Johnson & Johnson, Pancreum LLC, JDRF, Tandem Diabetes Care, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  May 2016
Category:  Medical Devices
Report ID:   57854
Report Format:   PDF
Pages:   120
Rating:    4.3 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support